GB202112976D0 - Novel treatments - Google Patents

Novel treatments

Info

Publication number
GB202112976D0
GB202112976D0 GBGB2112976.2A GB202112976A GB202112976D0 GB 202112976 D0 GB202112976 D0 GB 202112976D0 GB 202112976 A GB202112976 A GB 202112976A GB 202112976 D0 GB202112976 D0 GB 202112976D0
Authority
GB
United Kingdom
Prior art keywords
novel treatments
treatments
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2112976.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oncopeptides AB
Original Assignee
Oncopeptides AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncopeptides AB filed Critical Oncopeptides AB
Priority to GBGB2112976.2A priority Critical patent/GB202112976D0/en
Publication of GB202112976D0 publication Critical patent/GB202112976D0/en
Priority to PCT/EP2022/068974 priority patent/WO2023281007A1/en
Priority to EP22747660.3A priority patent/EP4366721A1/en
Priority to CN202280058782.7A priority patent/CN117940119A/en
Priority to TW111125748A priority patent/TW202317084A/en
Ceased legal-status Critical Current

Links

GBGB2112976.2A 2021-07-08 2021-09-10 Novel treatments Ceased GB202112976D0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
GBGB2112976.2A GB202112976D0 (en) 2021-09-10 2021-09-10 Novel treatments
PCT/EP2022/068974 WO2023281007A1 (en) 2021-07-08 2022-07-07 Melflufen for use in the treatment of multiple myeloma
EP22747660.3A EP4366721A1 (en) 2021-07-08 2022-07-07 Melflufen for use in the treatment of multiple myeloma
CN202280058782.7A CN117940119A (en) 2021-07-08 2022-07-07 Meflofen for the treatment of multiple myeloma
TW111125748A TW202317084A (en) 2021-07-08 2022-07-08 Novel treatments

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2112976.2A GB202112976D0 (en) 2021-09-10 2021-09-10 Novel treatments

Publications (1)

Publication Number Publication Date
GB202112976D0 true GB202112976D0 (en) 2021-10-27

Family

ID=78149217

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2112976.2A Ceased GB202112976D0 (en) 2021-07-08 2021-09-10 Novel treatments

Country Status (2)

Country Link
CN (1) CN117940119A (en)
GB (1) GB202112976D0 (en)

Also Published As

Publication number Publication date
CN117940119A (en) 2024-04-26

Similar Documents

Publication Publication Date Title
GB202006390D0 (en) Novel treatments
GB202016058D0 (en) Therapeautic treatment
GB202003722D0 (en) Treatment
GB202002711D0 (en) Treatment
GB202116339D0 (en) Novel treatments
GB202112977D0 (en) Novel treatments
GB202112981D0 (en) Novel treatments
GB202112980D0 (en) Novel treatments
GB202112979D0 (en) Novel treatments
GB202112978D0 (en) Novel treatments
GB202112976D0 (en) Novel treatments
GB202109895D0 (en) Novel treatments
GB202109894D0 (en) Novel treatments
GB202109896D0 (en) Novel treatments
GB202103400D0 (en) Novel treatments
GB202101291D0 (en) Novel treatments
GB202101292D0 (en) Novel treatments
GB202101296D0 (en) Novel treatments
GB202017858D0 (en) Novel treatments
GB202010259D0 (en) Novel Treatments
GB202317035D0 (en) Novel treatments
GB202316907D0 (en) Novel treatments
GB202205070D0 (en) Novel treatments
GB202205069D0 (en) Novel treatments
GB202009086D0 (en) New treatments

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)